Skip to main content
AVR
NASDAQ Industrial Applications And Services

Anteris Technologies Announces Public Offering and Strategic Private Placement Totaling Up to $290M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$6.2
Mkt Cap
$236.886M
52W Low
$2.34
52W High
$8.79
52W Position info
165% above low
Off High info
29% below high
Rel. Volume info
4.6× avg
Market data snapshot near publication time

AVR has more than doubled off its 52-week low of $2.34 on elevated volume (4.6× avg).

Summary

Anteris Technologies Global Corp. is raising up to $290 million through a public offering and a concurrent private placement with a Medtronic plc subsidiary, addressing its 'going concern' warning and funding critical clinical trials.


Key Events · Financing and Capital Events · AVR

  • Significant Capital Raise

    Anteris Technologies is conducting a public offering of $200 million in common stock and a concurrent private placement of up to $90 million, totaling up to $290 million.

  • Strategic Investment by Medtronic Subsidiary

    Covidien Group S.à r.l., a wholly-owned subsidiary of Medtronic plc, is participating in the private placement at the public offering price, with a maximum purchase of 19.99% of outstanding shares post-offering.

  • Addresses Going Concern

    This financing is critical for the company, which previously disclosed 'substantial doubt about its ability to continue as a going concern,' providing essential capital for operations.

  • Funding for Pivotal Trial

    Proceeds will primarily fund the ongoing PARADIGM Trial for the DurAVR® Transcatheter Heart Valve System and expand manufacturing capabilities.


Analysis · AVR · Industrial Applications And Services

This substantial capital raise is critical for Anteris Technologies, a development-stage company that explicitly disclosed "substantial doubt about its ability to continue as a going concern." The up to $290 million in new funding, which represents a significant portion of its current market capitalization, will be used to advance its pivotal PARADIGM Trial for the DurAVR® THV System, expand manufacturing, and support general operations. While highly dilutive, this financing provides a necessary lifeline, removing immediate liquidity concerns and enabling the company to progress its key product development. The concurrent private placement with a Medtronic plc subsidiary is a significant strategic development, offering validation for Anteris' technology and potential future collaboration opportunities, including a non-voting board observer right and negotiation rights for future acquisition proposals.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AVR was trading at $6.20 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $236.9M. The 52-week trading range was $2.34 to $8.79. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AVR - Latest Insights

AVR
Nov 10, 2026, 5:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.90
Real-time Price: $5.09 info
Change: -$0.810 (-14%) info
Market Cap: $486.492M info
AVR
Nov 10, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.89
Real-time Price: $5.09 info
Change: -$0.800 (-14%) info
Market Cap: $486.492M info
AVR
Oct 06, 2026, 6:18 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.51
Real-time Price: $5.09 info
Change: -$2.42 (-32%) info
Market Cap: $486.492M info
AVR
Oct 01, 2026, 8:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.61
Real-time Price: $5.09 info
Change: -$2.52 (-33%) info
Market Cap: $486.492M info
AVR
Aug 12, 2026, 6:13 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.84
Real-time Price: $5.09 info
Change: -$3.75 (-42%) info
Market Cap: $486.492M info